Ophthalmologic findings following intrathecal AAV9 mediated gene transfer for Giant Axonal Neuropathy

被引：0
|
作者：
Bharucha-Goebel, D. [1 ,2 ]
Saade, D. [1 ]
Todd, J. [1 ,3 ]
Huryn, L. [4 ]
Norato, G. [3 ]
DeLong, T. [1 ]
Averion, G. [1 ]
Donkervoort, S. [1 ]
Foley, A. [1 ]
Acquaye, N. [1 ]
Mendoza, C. [1 ]
Gray, S. [5 ]
Zein, W. [4 ]
Bonnemann, C. [1 ]
机构：
[1] NIH, Neuromuscular & Neurogenet Disorders Childhood Se, Bethesda, MD USA
[2] Childrens Natl Hosp, Div Neurol, Washington, DC USA
[3] NIH, Off Clin Director, Bethesda, MD USA
[4] NEI, NIH, Bethesda, MD USA
[5] UT Southwestern Med Ctr, Dept Paediat, Dallas, TX USA
来源：
NEUROMUSCULAR DISORDERS | 2023年 / 33卷
关键词：
D O I：
10.1016/j.nmd.2023.07.482
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P444
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [41] Vector Biodistribution and Transgene Expression in the Heart Following Gene Transfer of AAVrh.10 vs. AAV9 Capsids
    Selvan, Nithya
    Nair, Anju
    Fargnoli, Anthony S.
    Zhang, Jing
    Wang, Jie
    Bradford, William H.
    Granados, Sonia Gutierrez
    Law, Kenneth M.
    Fenn, Tim
    McCormac, Paul
    Barth, Jay
    Sheikh, Farah
    Khanna, Richie
    MOLECULAR THERAPY, 2023, 31 (04) : 590 - 590
  • [42] A Single Intravenous AAV9 Injection Mediates Bilateral Gene Transfer to the Adult Mouse Retina
    Bemelmans, Alexis-Pierre
    Duque, Sandra
    Riviere, Christel
    Astord, Stephanie
    Desrosiers, Melissa
    Marais, Thibault
    Sahel, Jose-Alain
    Voit, Thomas
    Barkats, Martine
    PLOS ONE, 2013, 8 (04):
  • [43] Improved heart specific gene transfer of AAV9 vectors with microRNA regulated transgene expression
    Geisler, Anja
    Jungmann, Andreas
    Vetter, Roland
    Muller, Oliver
    Fechner, Henry
    HUMAN GENE THERAPY, 2009, 20 (11) : 1381 - 1381
  • [44] AAV9 gene transfer to the nose for pharmacologically-regulated systemic expression of therapeutic proteins
    Limberis, M. P.
    Wilson, J. M.
    HUMAN GENE THERAPY, 2011, 22 (10) : A21 - A22
  • [45] Tracking ABCD1 Expression Using HATagged ABCD1 Following Intrathecal AAV9 Delivery
    Gong, Yi
    Berenson, Anna
    Laheji, Fiza
    Volak, Adrienn
    Maguire, Casey
    Eichler, Florian
    MOLECULAR THERAPY, 2018, 26 (05) : 327 - 327
  • [46] AAV-mediated gene transfer protects against mitochondrial optic neuropathy
    Lewin, AS
    Qi, XP
    Sun, L
    Guy, J
    FASEB JOURNAL, 2006, 20 (05): : A920 - A920
  • [47] Gene Therapy for Familial ALS Using AAV9 Mediated Silencing of Mutant SOD1
    Iannitti, Tommaso
    Scarrot, Joseph M.
    Coldicott, Ian R. P.
    Kaspar, Brian K.
    Ferraiuolo, Laura
    Shaw, Pamela J.
    Azzouz, Mimoun
    HUMAN GENE THERAPY, 2016, 27 (07) : A12 - A12
  • [48] Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
    Inagaki, Katsuya
    Fuess, Sally
    Storm, Theresa A.
    Gibson, Gregory A.
    Mctiernan, Charles F.
    Kay, Mark A.
    Nakai, Hiroyuki
    MOLECULAR THERAPY, 2006, 14 (01) : 45 - +
  • [49] Efficient CNS, PNS, and Visceral Gene Delivery Following Fetal and Neonatal Intravenous Administration of AAV9
    Rahim, A. A.
    Wong, A. M.
    Hoeffer, K.
    Buckley, S. M.
    Mattar, C.
    Chan, J.
    Cooper, J. D.
    Waddington, S. N.
    HUMAN GENE THERAPY, 2010, 21 (04) : 505 - 506
  • [50] AAV9 mediates more specific cardiac gene transfer in the rat than AAV2, AAV5, AAV7, and AAV8
    Qi, Yanfei
    Liu, Xuan
    Li, Hongwei
    Shenoy, Vinayak
    Li, Qiuhong
    Hauswirth, William W.
    Sumners, Colin
    Katovich, Michael J.
    FASEB JOURNAL, 2009, 23
12345